Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
- Conditions
- Fetal Membranes, Premature Rupture
- Interventions
- Procedure: Retention of CerclageProcedure: Removal of CerclageProcedure: Removal vs. Retention of Cervical Cerclage
- Registration Number
- NCT00201656
- Lead Sponsor
- Obstetrix Medical Group
- Brief Summary
The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
- Detailed Description
The placement of cervical cerclage is standard of care for women who experience incompetent cervix. Treadwell et al, published the largest retrospective review of 482 patients receiving cerclage (364 elective and 118 emergent). They found premature rupture of membranes (PROM) in 38% of the subjects with 9% delivering \<27 weeks. Preterm birth is the cause of at least 75% of neonatal deaths that are not due to congenital malformations. The question of whether to remove cerclage after preterm premature rupture of membranes (PPROM) is one of the unresolved controversies in obstetrics because the few available studies are retrospective, all have small numbers of patients, and the studies have given conflicting results regarding the safety of retaining a cerclage after preterm premature rupture of the membranes. It is unclear from the retrospective studies whether latency (the interval from membrane rupture to the onset of labor) is prolonged with retention of the suture. Furthermore, some, but not all studies suggest an increase in major infectious maternal morbidity and possibly neonatal morbidity. For this reason, clinicians vary greatly in deciding on whether to remove a cerclage in a patient with PPROM and either practice is currently an acceptable standard. This is a fairly rare complication, the combination of PPROM in a patient with cerclage in place only occurs in about 1-3/1000 pregnant women. Thus it has been impossible to study this problem prospectively in any single institution. The establishment of the Obstetrix Collaborative Research Group affords the unique opportunity to study this rare complication. Obstetrix manages 19 practices of Perinatologists around the U.S. and Mexico and is comprised of nearly 100 such subspecialists. This problem is most often referred to a Perinatologist when it occurs, so it is not unusual for these practices to see 5 - 10 such patients per year. Obstetrix fully funds the infrastructure of this research group and inclusion in this study will not alter the cost of patient care in either group as there is virtually no cost in removing the cerclage and all these patients are kept in hospital until delivery when membranes rupture as standard of care.
This is a multicenter trial. The purpose is to determine whether retention of cerclage after preterm premature rupture of the membranes improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 58
- A previously placed prophylactic cerclage defined as any cerclage done < 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation < 3 cm
- Spontaneous rupture of membranes 22-32 weeks
- Singleton or twin gestation
- Shirodkar or McDonald cerclage in place > 1 week
- Active labor (> 8 uterine contractions [UCs] per hour)
- Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness
- Placenta previa or undiagnosed vaginal bleeding
- Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)
- Mature pulmonary studies
- Positive gram stain, culture, white blood cells (WBC) > 30, or glucose < 14 on amniocentesis
- Major fetal anomaly
- Presentation > 48 hours after rupture of membranes
- abdominal cerclage
- Cerclage done for symptomatic cervical dilation (cervix dilated > 3 cm)
- Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Retention of Cerclage Retention of Cerclage Group one = Subject whose Cerclage is retained after randomization. 2 - Removal of Cerclage Removal of Cerclage Group 2 = Subjects who will have cerclage removed after randomization 1 Retention of Cerclage Removal vs. Retention of Cervical Cerclage Group one = Subject whose Cerclage is retained after randomization. 2 - Removal of Cerclage Removal vs. Retention of Cervical Cerclage Group 2 = Subjects who will have cerclage removed after randomization
- Primary Outcome Measures
Name Time Method Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness conception to birth Grade 3 or 4 intraventricular hemorrhage birth to 28days of life Stage 2 or 3 necrotizing enterocolitis birth to 28days of life Neonatal intensive care unit (NICU) stay birth to 28days of life Birth weight at birth Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal death Birth to 28days of life Respiratory distress syndrome birth to 28days of life Documented sepsis within 72 hours of delivery birth to 72 hours after delivery Estimated gestational age (EGA) at delivery at delivery Postpartum endometritis birth to 28days of life Maternal sepsis birth to 28days following delivery Latency labor to delivery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (22)
Tucson Medical Center
🇺🇸Tucson, Arizona, United States
Desert Good Samaritan Hospital
🇺🇸Mesa, Arizona, United States
University of Illinois at Chicago
🇺🇸Chicago, Illinois, United States
Erlanger Medical Center
🇺🇸Chattanooga, Tennessee, United States
Long Beach Memorial Medical Center
🇺🇸Long Beach, California, United States
Yale New-Haven Medical Center
🇺🇸New Haven, Connecticut, United States
Memorial Hermann Children's Hospital-Texas Center for Fetal Assessment
🇺🇸Houston, Texas, United States
Evergreen Hospital
🇺🇸Kirkland, Washington, United States
Good Samaritan Hospital
🇺🇸San Jose, California, United States
University of Rochester Medical Center
🇺🇸Rochester, New York, United States
Sunrise Medical Center
🇺🇸Las Vegas, Nevada, United States
Banner Good Samaritan Hospital
🇺🇸Phoenix, Arizona, United States
Swedish Medical Center
🇺🇸Seattle, Washington, United States
Saddleback Memorial Medical Center
🇺🇸Laguna Hills, California, United States
University of Southern California-Irvine Medical Center
🇺🇸Orange, California, United States
The University Hospital
🇺🇸Cincinnati, Ohio, United States
Saint Luke's Hospital, Kansas City
🇺🇸Kansas City, Missouri, United States
Lousiana State University Health Science
🇺🇸Shreveport, Louisiana, United States
Rose Medical Center
🇺🇸Denver, Colorado, United States
Sacred Heart Medical Center
🇺🇸Eugene, Oregon, United States
Hutzel Women's Hospital
🇺🇸Detroit, Michigan, United States
Presbyterian/St Luke's Hospital
🇺🇸Denver, Colorado, United States